<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0163945.ref026">
 <label>26</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Feld</surname>
   <given-names>JJ</given-names>
  </name>, 
  <name>
   <surname>Kowdley</surname>
   <given-names>KV</given-names>
  </name>, 
  <name>
   <surname>Coakley</surname>
   <given-names>E</given-names>
  </name>, 
  <name>
   <surname>Sigal</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Nelson</surname>
   <given-names>DR</given-names>
  </name>, 
  <name>
   <surname>Crawford</surname>
   <given-names>D</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin</article-title>. 
  <source>N Engl J Med</source>. 
  <year>2014</year>;
  <volume>370</volume>(
  <issue>17</issue>):
  <fpage>1594</fpage>â€“
  <lpage>603</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa1315722</pub-id> .
  <?supplied-pmid 24720703?>
  <pub-id pub-id-type="pmid">24720703</pub-id>
 </mixed-citation>
</ref>
